EBS
Emergent Biosolutions Inc
6.60$
-3.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.4% | – | – | +45.3% | +137.5% | +14.8% | +6.3% | +18.5% | +45.2% | +9.3% | +3.2% | +11.1% | +50.8% | +10.4% | -7.0% | +10.3% | +108.3% | +4.4% | +23.9% | +2.6% | +7.1% | -42.4% | -23.8% | -5.1% | |
| – | -99.6% | – | – | +41.8% | +149.2% | -2.1% | +5.8% | +26.9% | +25.6% | +4.5% | +3.5% | +3.7% | +58.2% | +24.6% | -5.3% | -4.9% | +27.9% | +10.5% | +74.3% | +6.2% | -4.7% | -43.9% | -11.9% | +10.7% | |
| – | -16.5% | – | – | +432.1% | +110.6% | +38.4% | -13.5% | +12.5% | +64.2% | -14.9% | -1.6% | +26.6% | +56.4% | +11.5% | -13.2% | -34.3% | -37.1% | +49.7% | +269.8% | -7.2% | +11.5% | -82.6% | -10.9% | +106.4% | |
| – | -16.5% | – | – | +432.1% | +110.6% | +38.4% | -13.5% | +12.5% | +66.2% | -14.7% | -2.9% | +26.6% | +56.4% | +11.5% | -13.2% | -34.3% | -37.1% | +49.7% | +269.8% | -7.2% | +11.5% | -82.6% | -10.9% | +106.4% | |
| – | – | – | – | -82.3% | +1,242.2% | -57.4% | +32.1% | +171.4% | -28.8% | +74.1% | +14.8% | -31.0% | -9.1% | +111.6% | +16.6% | -1.6% | +79.7% | +4.9% | -16.1% | +20.8% | -42.9% | +20.0% | -19.1% | -45.5% | |
| – | – | – | – | +24.1% | +50.4% | -31.6% | +16.8% | -31.5% | -5.9% | +15.2% | +3.4% | -3.4% | +348.5% | +17.1% | -3.8% | +93.0% | +44.1% | +8.1% | +38.0% | +12.2% | +1.8% | -6.2% | -5.2% | +10.2% | |
| – | – | – | – | +12.4% | +155.1% | +41.0% | +13.1% | +5.8% | +15.8% | +36.9% | +15.7% | +9.3% | +18.8% | +5.7% | +13.4% | +8.2% | +25.3% | +6.3% | +18.8% | +24.2% | +2.2% | -51.2% | -29.2% | -23.5% | |
| – | – | – | – | – | – | – | – | – | – | +9.4% | +0.0% | +153.6% | +200.9% | +30.8% | -25.3% | +19.8% | +428.6% | +2.7% | +0.0% | -15.7% | -3.0% | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | +0.0% | -18.7% | +72.1% | +89.2% | -26.6% | -66.1% | +253.2% | +578.6% | -8.6% | -10.6% | -8.8% | +20.5% | -22.3% | -11.5% | -13.0% | |
| – | -67.7% | – | – | -12.0% | +145.8% | +2.6% | -10.7% | +10.3% | +25.7% | +2.7% | -6.2% | +12.6% | +185.2% | -2.2% | -2.5% | -57.8% | +671.9% | +1.7% | +15.9% | -6.3% | +32.1% | -34.0% | -22.7% | -12.2% | |
| – | – | – | – | -12.0% | +113.8% | -13.5% | -2.9% | +1.3% | +38.4% | -6.2% | -12.9% | -8.5% | +64.1% | +7.2% | +6.3% | -5.5% | +100.3% | +7.9% | +77.8% | -2.7% | +228.6% | -47.0% | -75.1% | -18.6% | |
| – | – | – | – | +34.6% | +709.9% | +34.6% | +38.5% | -2.2% | -17.3% | -68.8% | -16.6% | +480.6% | +54.8% | +7.4% | -53.7% | +113.6% | -76.4% | +62.4% | +173.8% | -16.7% | +2,475.1% | -57.0% | -99.3% | -100.0% | |
| – | – | – | – | +88.9% | +162.5% | -34.3% | +1.5% | -6.0% | +48.1% | +59.5% | -22.8% | -12.1% | +48.7% | +12.3% | -24.6% | +20.5% | +93.3% | +17.5% | +43.6% | -5.3% | -19.7% | +8.4% | -45.7% | -8.7% | |
| – | – | – | – | -11.2% | +198.7% | +35.8% | -15.6% | +25.0% | -32.7% | +78.9% | +7.8% | +6.3% | +304.8% | +0.8% | -1.9% | -94.6% | +5,729.7% | +1.8% | +5.3% | -3.8% | -44.6% | -0.4% | +48.6% | -13.8% | |
| – | – | – | – | +160.3% | +131.8% | +23.6% | +16.5% | +21.0% | +53.2% | +12.1% | +6.5% | +10.8% | +13.1% | +19.3% | -9.7% | +53.0% | +10.8% | +7.7% | +32.9% | +11.4% | -13.9% | -53.2% | -25.6% | +8.2% | |
| – | – | – | – | +65.8% | +89.0% | +46.5% | +29.4% | +34.2% | +42.3% | +13.2% | +11.9% | +14.1% | +14.6% | +21.8% | -27.5% | +32.5% | +9.0% | +14.8% | +72.3% | +30.7% | -22.3% | -103.0% | – | – | |
| – | +12.6% | -2.3% | +0.6% | +11.3% | +8.0% | +20.7% | +2.7% | +3.0% | +3.7% | +11.3% | +0.6% | +0.9% | +24.6% | +3.2% | +4.4% | +2.0% | +2.1% | +1.9% | +2.7% | +0.6% | -7.4% | +2.2% | +3.5% | +7.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.